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Summary
Introduction: Staphylococcus aureus, Kingella kingae and -hemolytic streptococcus are
presently the most frequently identiﬁed bacteria in child haematogenous osteoarticular infec-
tion.
Objective: To determine the microbiological proﬁle (bacteria and antibiotic susceptibility) of
osteoarticular infections in a paediatric hospital, so as to adapt treatment protocols to the
ecology of the bacteria isolated.
Patients and methods: Prospective descriptive study, including children admitted for acute
osteomyelitis or septic arthritis. A series of blood cultures was performed systematically on
admission. In case of surgery, local samples were taken for bacteriology. Antibiotherapy was
initiated and subsequently adapted to the bacteriological ﬁndings.
Results: One hundred and six children were included. Thirty-ﬁve were under (Group 1) and
71 over 3 years of age (Group 2). Ninety-ﬁve underwent surgery. Peroperative samples were
positive in 61 cases and blood culture in 23. Bacteria were isolated in 22 patients in G1.
Extended-spectrum -lactamase-producing Klebsiella pneumoniae was isolated in ﬁve neonates
who had passed through intensive care. Staphylococcus aureus was the most frequently isolated
bacterium in G2 (n = 40), and was methicillin-resistant (MRSA) in six children.
Discussion: Methicillin-susceptible Staphylococcus aureus was the most frequently isolated
microorganism. Other than neonates who had passed through intensive care and the six patients
MRSAwith community-acquired
generation cephalosporins.
Level of evidence: II, prospectiv
© 2011 Elsevier Masson SAS. All
∗ Corresponding author. Tel.: +216 99323374; fax: +216 71570932.
E-mail address: mehditrifa@yahoo.fr (M. Trifa).
877-0568/$ – see front matter © 2011 Elsevier Masson SAS. All rights re
oi:10.1016/j.otsr.2010.10.005infection, all isolated bacteria were susceptible to second-e descriptive prognostic study.
rights reserved.
served.
ctio
a
(
t
o
v
l
•
•
a
a
•
•
i
r
b
a
c
(
(
l
a
w
t
v
R
O
•
•
S
S
A
t
(
a
t
a
BMicrobiological proﬁle of haematogenous osteoarticular infe
Introduction
Childhood osteoarticular infection is a frequent cause of
hospital admission in paediatric orthopaedics. It requires
rapid medical and surgical care, associating antibiotherapy
and possible surgical drainage [1]. Empiric antibiother-
apy should target the bacteria most frequently isolated
in such infections: Staphylococcus aureus, Kingella kingae
and -hemolytic streptococcus [2]. Community-associated
methicillin-resistant Staphylococcus aureus (MRSA), impli-
cated in community-acquired childhood osteoarticular
infection, is becoming increasingly common, especially in
reports from North America [3,4].
Several treatment protocols have been published over
the last decade [5—7]. The Paediatric Infectious Pathology
Group of the French Paediatrics Society (Groupe de patholo-
gie infectieuse pédiatrique, Société franc¸aise de pédiatrie)
recently published guidelines for the prescription of empiric
antibiotherapy in community-acquired childhood osteoar-
ticular infection [8], based on cloxacillin, cefamandole,
cefuroxime or amoxicillin-clavulanic acid monotherapy.
The present study compared the bacteriological proﬁle
(bacteria and antibiotic susceptibility) of childhood osteoar-
ticular infections in our paediatric hospital to the literature
data so as either to adopt the above recommendations or to
adapt the treatment protocol to the ecology of the bacteria
isolated.
Material and methods
Approval was obtained from the local ethics committee and
informed consent from the patients’ parents for a prospec-
tive descriptive study run over an 18-month period (July
2005 to December 2006) including all children admitted to
the Tunis Children’s Hospital for hematogenic osteoarticular
infection (septic arthritis or acute osteomyelitis), with the
exception of those having already received antibiotherapy
prior to admission.
Acute osteomyelitis (AOM) was diagnosed from clinical
signs (bone pain generally associated with infectious syn-
drome) and positive blood culture and/or culture of local
samples in case of surgery or, in the absence of positive
microbiology, from clinical signs and signs of bone infec-
tion on magnetic resonance imaging (MRI) and/or 99mTc
(metastable technetium-99)-marked diphosphonate 3-phase
bone scintigraphy.
Septic arthritis was diagnosed from pain associated with
joint effusion and infectious syndrome. In these cases, joint
puncture was systematic. Diagnosis was deﬁnite in case of
positive culture of puncture sample and/or blood; in the
absence of positive microbiology, diagnosis was founded on
a slightly turbid or frankly purulent aspect of the joint sam-
ple, associated with an inﬂammatory white-cell count, and
positive response to antibiotherapy.
A series of three blood cultures was performed system-
atically on admission of all the included patients. Septic
arthritis patients all underwent surgical drainage of intra-
articular effusion and joint cleansing by arthrotomy. In AOM,
surgery was indicated for subperiosteal abscess found on
initial ultrasound scan or control scans performed under
antibiotherapy. Surgery consisted in draining the abscess,
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nd bone drilling for medullary cleansing. Local samples
pus in osteomyelitis and joint liquid in septic arthritis) were
aken for bacteriology during joint and/or bone surgery. Part
f the sample was directly inoculated into a blood-culture
ial and sent with the rest of the sample to the microbiology
aboratory.
Patients were divided into two age groups:
group 1 (G1): < 3 years;
group 2 (G2): ≥ 3 years.
Empiric IV antibiotherapy (cefotaxime/fosfomycin in G1,
nd oxacillin/gentamycin in G2) was prescribed in both AOM
nd septic arthritis:
after peroperative sampling (POS) in case of primary
surgery;
after sampling for blood culture (BC) where surgery was
either not indicated (obvious osteoarticular infection) or
secondary.
In the laboratory, blood culture vials were incubated
n a BactAlert incubator (bioMérieux) for two weeks. The
emainder of the sample underwent direct examination with
lood count and bacterium detection after Gram staining
nd culture on appropriate gel substrate. In case of positive
ulture, strains were identiﬁed by conventional methods
Gram staining, catalase and oxidase) and the Api System
bioMérieux). Susceptibility was studied by antibiogram, fol-
owing the CA-SFM standard [9].
Empiric antibiotherapy was adapted as need be to the
ntibiogram ﬁndings. Antibiotherapy was pursued for six
eeks, including two weeks parenterally.
Statistical analysis used SPSS 10.0 software. Quantita-
ive variables were expressed as mean± SD and qualitative
ariables as percentages.
esults
ne hundred and six children were included:
group 1: 35 children (33%), including eight neonates (7.5%
of osteoarticular infections in the series);
group 2: 71 children (67%).
Mean age was 6± 4.5 years (range, 13 days to 16 years).
eventy boys and 36 girls were included (sex ratio, 1.94).
ixty-six cases (62%) were of septic arthritis, and 40 (38%) of
OM. Arthritis principally involved the knee or hip (respec-
ively, 25 and 23 cases); AOM principally involved the femur
15 cases). The children in G1 mainly presented with septic
rthritis (83%).
In the 95 patients who underwent surgery, a POS was
aken. Sixty-nine children (65.1%) had positive culture (POS
nd/or BC, Table 1), including 16 positive on both POS and
C. One child, in G2, showed polymicrobial infection (two
acteria detected in POS).
Bacteria were isolated in 22 of the 35 under-3 year-olds
G1). Fifty-ﬁve percent (n = 12) were Gram-positive (GPB)
nd 45% (n = 10) Gram-negative bacteria (GNB). Staphylo-
occus aureus was isolated in seven patients, and was in
188 M. Trifa et al.
Table 1 Number of positive bacteriological samples.
G1 (%)
(n = 35)
G2 (%)
(n = 71)
Total (%)
(n = 106)
Positive isolate 22 (63) 47 (66) 69 (65.1)
Operated patients 33 (94) 62 (87) 95 (89.6)
a
i
p
s
s
f
f
r
2
O
m
g
1
A
s
D
T
c
a
t
l
i
[
y
a
n
u
B
s
s
s
[
l
b
o
a
i
I
G
b
m
h
b
c
c
iPositive POS 20/33 (60)
Positive BC 5 (14)
POS: peroperative sample; BC: blood culture.
ll cases methicillin-susceptible. Klebsiella pneumoniae was
solated in ﬁve neonates managed in ICU during the days
receding referral to our department, and was extended-
pectrum -lactamase-producing (ESBL) in all cases. No
amples were positive for Kingella Kingae. S. aureus was by
ar the most frequent bacterium in over-3 year-olds (G2),
ound in 40 of the 47 positive samples, and was methicillin-
esistant in six cases (Table 2).
Initial antibiotherapy was adapted to the antibiogram in
0 patients in G1: i.e., 91% of those with positive culture.
ther than K. pneumonia, isolated exclusively in neonates
anaged in ICU, all bacteria were susceptible to second-
eneration cephalosporins.
Initial antibiotherapy was adapted to the antibiogram in
2 patients in G2: i.e., 26% of those with positive culture.
part from MRSA, bacteria were likewise susceptible to
econd-generation cephalosporins.
iscussion
he present study examined the bacteriological proﬁle of
hildhood osteoarticular infections, with a view to selecting
n empiric antibiotherapy protocol from those published in
he recent literature. Patients were grouped for age: G1
ess than 3 years, G2 greater or equal to 3 years. This group-
ng was also used by Moumile et al. [10]; Bonhoeffer et al.
11] used three age groups: 0—4 years, 5—9 years and 10—14
ears; Timsit et al. [12] also used three age groups: 0—2, 2—6
nd > 6 years. Other studies focused on a single age group:
y
[
d
o
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Table 2 Bacteriological isolates.
G1 (n = 35)
Neonate
Yes No
Positive isolate 8 14
MSSA 1 6
MRSA 0 0
Streptococcus A 1 2
Streptococcus B 1 0
Pneumococcus 0 1
Enterobacter cloacae 0 3
ESBL Klebsiella pneumoniae 5 0
Salmonella enteritidis 0 2
MSSA: methicillin-susceptible Staphylococcus aureus; MRSA: methicill
lactamase-producing.41/62 (66) 61/95 (64)
18 (25) 23 (21.7)
eonates [13,14]. The present rate of neonate osteoartic-
lar infection (7.5%) was comparable to that reported by
onhoeffer et al. [11] (7.4%). The sex ratio in the present
tudy was 1.94; male predominance was also found in other
eries [10,11,15].
Bacteriology was positive in 69 patients (65.1%), a result
imilar to those of Wang et al. [16] and Bonhoeffer et al.
11]. Timsit et al. reported 29% positive cultures, much
ower than usually found in the literature; this may have
een due to broader inclusion criteria, increasing the rate
f false negatives, or to the large number of infections (16%)
ffected by prior antibiotherapy [12].
Surgery was indicated for 89.6% of patients, a result sim-
lar to those of Wang et al. [16] and Lyon and Evanich [17].
n contrast, only 66% of Timsit’s patients [12] and 50% of
oergens’ [18] were operated on; this difference may have
een due to differences in diagnostic and inclusion criteria.
Blood culture was positive in 21.7% of patients, in agree-
ent with the literature [10,17—19]. Bonhoeffer et al. [11],
owever, reported 52% positive blood cultures; this may have
een due to his considering coagulase-negative Staphylo-
occus (13% of positive BCs) as an infective rather than a
ontaminant agent, unlike most other authors.
In the present series, GPB and GNB were almost equally
mplicated in the osteoarticular infections of the under-3
ear-olds (G1), in agreement with most of the literature
10,12]. Bonhoeffer et al. [11], in contrast, found GPB pre-
ominance (72%); this may have been due to his inclusion
f children up to the age of 4 years. The present rate
f S. aureus infection (32%) was comparable to those of
G2(n = 71) Total(n = 106)
Total
22 47 69
7 (32%) 34 (72%) 41 (59%)
0 6 (13%) 6 (9%)
3 (14%) 5 (11%) 8 (12%)
1 0 1
1 0 1
3 (14%) 1 (2%) 4 (6%)
5 (23%) 0 5 (7%)
2 (9%) 1 (2%) 3 (4%)
in-resistant Staphylococcus aureus; ESBL: extended-spectrum -
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Bonhoeffer et al. [11] (36%), Timsit et al. (22%) [12] and
Moumile et al. (16%) [10]; S. aureus was likewise methicillin-
susceptible in those series [10—12]. GNB were isolated in
10 G1 patients (45% of positive cultures). This result was
similar to those of Timsit et al. [12] and Moumile et al.
[10]. K. kingae has been the most frequently isolated GNB in
the most recent studies [10,12,20], whereas Haemophilus
inﬂuenzae was the most frequent in studies performed in
the 1990s [15,21]. This change in microbiological proﬁle
may be due to the spread of anti-Haemophilus b vacci-
nation. The absence of K. kingae as GNB isolated in the
present study is noteworthy, despite good technical compli-
ance and adherence to the 2-week incubation required with
the BactAlert apparatus (bioMérieux). K. kingae is an emerg-
ing pathogen, which is very difﬁcult to culture, and belongs
to the HACEK group [20]; in the present study, microbi-
ological diagnosis was based solely on culture, which is
not an efﬁcient technique for K. kingae. Universal poly-
merase chain reaction (PCR) ampliﬁes the gene coding for
16S rRNA, and has enhanced detection of K. kingae [22];
there are several reports of PCR detection of K. kingae
from culture-negative osteoarticular samples [22—24]. The
recent use by certain teams of speciﬁc real-time PCR fur-
ther increased sensitivity for K. kingae in pathologic samples
[25,26] so that K. Kingae is now ranking ﬁrst in certain
series of childhood osteoarticular infection [27]. Accord-
ing to Cherkaoui et al., real-time PCR, by amplifying a
gene speciﬁc to a bacterial cytotoxin, is much more sen-
sitive than universal PCR for the detection of K. kingae:
sensitivity is multiplied 10-fold [25]. The technique can
thus be very useful for conﬁrming microbiological diagnosis
of osteoarticular infection when the bacterial inoculum is
small.
Salmonella enteritidis was isolated in two G1 patients,
including one with sickle-cell disease. This result is in agree-
ment with the literature, where the rate varies from 3%
to 10% [10,12,15], with Salmonella enteritidis being the
most frequently implicated bacterium in sickle-cell disease
osteoarticular infection [28,29].
The eight neonates in G1 all had positive cultures, with
ESBL K. pneumoniae detected in ﬁve. Deshpande et al.,
studying the bacteriological proﬁle of neonatal osteoarticu-
lar infection, found a 55% rate of GNB infection, in which
K. pneumoniae predominated [13]; susceptibility was not
speciﬁed.
S. aureus was the mostly frequently isolated bacterium
in over-3 year-olds (G2), in agreement with most reports
[10,12]. Six of the 40 strains isolated were methicillin-
resistant (15%), a ﬁnding similar to those of Goergens et al.
[18] and Wang et al. [16] (respectively, 11% and 24%).
Martinez-Aguilar et al. [3], studying community-acquired
S. aureus osteoarticular infection, found 31 out of 59 strains
to be MRSA (52%). Arnold et al. [4], studying all osteoarticu-
lar infections, in both children and adults, found a 75% rate
of MRSA. This emergence of MRSA may be due to unjustiﬁed
prescription of antibiotics in children, especially by GPs.
Antibiotherapy was secondarily adapted for 20 G1 chil-
dren. The empiric antibiotherapy prescribed for under-3
year-olds in the present study was very broad-range, with
targets including MRSA, which was not in fact found in our
under-3 year-olds, in agreement with other reports [10—12].
Apart from ESBL K. pneumonia, found exclusively in ICUns in children 189
eonates, all other G1 isolates were susceptible to second-
eneration cephalosporins.
Initial antibiotherapy was secondarily adapted for 12 G2
atients: i.e., 26% of those with positive cultures. Adaption
ainly concerned MRSA infections.
The mean duration of antibiotherapy was six weeks,
ncluding two weeks’ parenteral administration. A review
f the literature published in 2007 concluded that
horter antibiotherapy, both for the intravenous phase and
verall, would be efﬁcient in childhood staphylococcal
steomyelitis, if the molecular pharmacokinetics was cor-
ect, especially in terms of absorption, and doses were high
30].
onclusion
n the present series, MSSA was the bacterium most fre-
uently isolated in childhood osteoarticular infection (59%
f cases). -hemolytic streptococcus was isolated in nine
hildren and GNB in 12. No samples showed positive for
ingella Kingae. MRSA was isolated in six children. ESBL
lebsiella pneumoniae was found in ﬁve neonates who had
een managed in ICU before referral. All the other microor-
anisms isolated were susceptible to second-generation
ephalosporins.
First-intention IV antibiotherapy based on cefamandole
r cefuroxime, awaiting bacteriological results, would seem
o suit the proﬁle of the bacteria isolated in the children of
he present series, with the exception of neonates from the
CU. Lack of clinical improvement in symptomatology may
uggest MRSA infection, in which case the empiric regimen
hould be replaced by one based on a glycopeptide.
onﬂict of interest statement
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